HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 182 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,406,140 | -49.5% | 42,911 | -45.8% | 0.00% | -40.0% |
| Q2 2023 | $2,786,479 | -6.3% | 79,184 | -13.1% | 0.01% | -16.7% |
| Q1 2023 | $2,975,263 | -20.8% | 91,124 | +33.7% | 0.01% | -25.0% |
| Q4 2022 | $3,754,753 | -5.3% | 68,140 | -23.9% | 0.01% | -11.1% |
| Q3 2022 | $3,965,000 | +14.5% | 89,508 | +27.2% | 0.01% | +28.6% |
| Q2 2022 | $3,462,000 | -11.9% | 70,387 | -12.8% | 0.01% | -12.5% |
| Q1 2022 | $3,928,000 | +59.1% | 80,746 | +39.5% | 0.01% | +60.0% |
| Q4 2021 | $2,469,000 | +1.1% | 57,894 | -9.1% | 0.01% | 0.0% |
| Q3 2021 | $2,442,000 | – | 63,718 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |